FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294680077> ?p ?o ?g. }

• W4294680077 endingPage "ii74" @default.
• W4294680077 startingPage "ii74" @default.
• W4294680077 abstract "Abstract Background IDH1/2 wildtype (IDHwt) glioma WHO grade 2 and 3 patients with pTERT mutation and/or EGFR amplification and/or +7/−10 chromosome gain/loss have a similar overall survival time as IDHwt glioblastoma patients, and are both considered glioblastoma IDHwt according to the WHO 2021 classification. However, differences in seizure onset have been observed. This study aimed to compare the course of epilepsy in the two glioblastoma subtypes. Material and Methods We analyzed epilepsy data of an existing cohort including IDHwt histologically lower-grade glioma WHO grade 2 and 3 with molecular glioblastoma-like profile (IDHwt hLGG) and IDHwt glioblastoma patients. Primary outcome was the incidence proportion of epilepsy during the disease course. Major secondary outcomes included onset of epilepsy, number of seizure days and antiepileptic drug (AED) polytherapy. Results Out of 254 patients, 78% (50/64) IDHwt hLGG and 68% (129/190) IDHwt glioblastoma patients developed epilepsy during the disease course (p=0.121). Epilepsy onset before histopathological diagnosis occurred more frequently in IDHwt hLGG compared to IDHwt glioblastoma patients (90% versus 60%, p&lt;0.001), with a significantly longer median time to diagnosis (3.5 versus 1.3 months, p&lt;0.001). Median total seizure days was also longer for IDHwt hLGG patients (7.0 versus 3.0, p=0.005), and they received more often AED polytherapy (32% versus 17%, p=0.028). Conclusion Although the incidence proportion of epilepsy during the entire disease course is similar, IDHwt hLGG patients show a significantly higher incidence of epilepsy before diagnosis and a significantly longer median time between first seizure and diagnosis compared to IDHwt glioblastoma patients, indicating a distinct clinical course." @default.
• W4294680077 created "2022-09-06" @default.
• W4294680077 creator A5000445750 @default.
• W4294680077 creator A5004901028 @default.
• W4294680077 creator A5011068333 @default.
• W4294680077 creator A5016495519 @default.
• W4294680077 creator A5018771146 @default.
• W4294680077 creator A5020207185 @default.
• W4294680077 creator A5022651335 @default.
• W4294680077 creator A5027431274 @default.
• W4294680077 creator A5027605304 @default.
• W4294680077 creator A5033587548 @default.
• W4294680077 creator A5038273452 @default.
• W4294680077 creator A5056837393 @default.
• W4294680077 creator A5076579541 @default.
• W4294680077 creator A5078165447 @default.
• W4294680077 creator A5090952286 @default.
• W4294680077 date "2022-09-01" @default.
• W4294680077 modified "2023-09-26" @default.
• W4294680077 title "P11.69.B <i>IDH1/2</i>wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to<i>IDH1/2</i>wildtype glioblastomas" @default.
• W4294680077 doi "https://doi.org/10.1093/neuonc/noac174.258" @default.
• W4294680077 hasPublicationYear "2022" @default.
• W4294680077 type Work @default.
• W4294680077 citedByCount "0" @default.
• W4294680077 crossrefType "journal-article" @default.
• W4294680077 hasAuthorship W4294680077A5000445750 @default.
• W4294680077 hasAuthorship W4294680077A5004901028 @default.
• W4294680077 hasAuthorship W4294680077A5011068333 @default.
• W4294680077 hasAuthorship W4294680077A5016495519 @default.
• W4294680077 hasAuthorship W4294680077A5018771146 @default.
• W4294680077 hasAuthorship W4294680077A5020207185 @default.
• W4294680077 hasAuthorship W4294680077A5022651335 @default.
• W4294680077 hasAuthorship W4294680077A5027431274 @default.
• W4294680077 hasAuthorship W4294680077A5027605304 @default.
• W4294680077 hasAuthorship W4294680077A5033587548 @default.
• W4294680077 hasAuthorship W4294680077A5038273452 @default.
• W4294680077 hasAuthorship W4294680077A5056837393 @default.
• W4294680077 hasAuthorship W4294680077A5076579541 @default.
• W4294680077 hasAuthorship W4294680077A5078165447 @default.
• W4294680077 hasAuthorship W4294680077A5090952286 @default.
• W4294680077 hasBestOaLocation W42946800771 @default.
• W4294680077 hasConcept C104317684 @default.
• W4294680077 hasConcept C118552586 @default.
• W4294680077 hasConcept C120665830 @default.
• W4294680077 hasConcept C121332964 @default.
• W4294680077 hasConcept C126322002 @default.
• W4294680077 hasConcept C127848430 @default.
• W4294680077 hasConcept C143998085 @default.
• W4294680077 hasConcept C187212893 @default.
• W4294680077 hasConcept C2776194525 @default.
• W4294680077 hasConcept C2778186239 @default.
• W4294680077 hasConcept C2778227246 @default.
• W4294680077 hasConcept C2779281540 @default.
• W4294680077 hasConcept C2910833928 @default.
• W4294680077 hasConcept C501734568 @default.
• W4294680077 hasConcept C502942594 @default.
• W4294680077 hasConcept C55493867 @default.
• W4294680077 hasConcept C61511704 @default.
• W4294680077 hasConcept C71924100 @default.
• W4294680077 hasConcept C72563966 @default.
• W4294680077 hasConcept C86803240 @default.
• W4294680077 hasConcept C90924648 @default.
• W4294680077 hasConceptScore W4294680077C104317684 @default.
• W4294680077 hasConceptScore W4294680077C118552586 @default.
• W4294680077 hasConceptScore W4294680077C120665830 @default.
• W4294680077 hasConceptScore W4294680077C121332964 @default.
• W4294680077 hasConceptScore W4294680077C126322002 @default.
• W4294680077 hasConceptScore W4294680077C127848430 @default.
• W4294680077 hasConceptScore W4294680077C143998085 @default.
• W4294680077 hasConceptScore W4294680077C187212893 @default.
• W4294680077 hasConceptScore W4294680077C2776194525 @default.
• W4294680077 hasConceptScore W4294680077C2778186239 @default.
• W4294680077 hasConceptScore W4294680077C2778227246 @default.
• W4294680077 hasConceptScore W4294680077C2779281540 @default.
• W4294680077 hasConceptScore W4294680077C2910833928 @default.
• W4294680077 hasConceptScore W4294680077C501734568 @default.
• W4294680077 hasConceptScore W4294680077C502942594 @default.
• W4294680077 hasConceptScore W4294680077C55493867 @default.
• W4294680077 hasConceptScore W4294680077C61511704 @default.
• W4294680077 hasConceptScore W4294680077C71924100 @default.
• W4294680077 hasConceptScore W4294680077C72563966 @default.
• W4294680077 hasConceptScore W4294680077C86803240 @default.
• W4294680077 hasConceptScore W4294680077C90924648 @default.
• W4294680077 hasIssue "Supplement_2" @default.
• W4294680077 hasLocation W42946800771 @default.
• W4294680077 hasOpenAccess W4294680077 @default.
• W4294680077 hasPrimaryLocation W42946800771 @default.
• W4294680077 hasRelatedWork W1965295928 @default.
• W4294680077 hasRelatedWork W1967986271 @default.
• W4294680077 hasRelatedWork W2035277224 @default.
• W4294680077 hasRelatedWork W2132282183 @default.
• W4294680077 hasRelatedWork W2170206357 @default.
• W4294680077 hasRelatedWork W2567911281 @default.
• W4294680077 hasRelatedWork W2618612696 @default.
• W4294680077 hasRelatedWork W2806306665 @default.
• W4294680077 hasRelatedWork W2910696677 @default.
• W4294680077 hasRelatedWork W4291991978 @default.
• W4294680077 hasVolume "24" @default.

• next